Home News & Events Events Events Page tools Share Share Share on FacebookShare on XShare on LinkedinShare on Bluesky Print Search Email Accessibility Filter events Filter events by clicking within the ‘Category’ drop-down list. Category - Any -IndustryWebinarsWorkshop Previous 1 2 3 In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events Webinars Workshops Webinars Social media Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related information: Solutions Webinars Solutions Industry events Solutions Workshops What's happening in ICON ICON Plc On 30 March – 2 April at the World Vaccine Congress, speak with ICON experts at booth 222 to learn how our experience across 180+ vaccine studies, end‑to‑end product development expertise, and fully integrated vaccine‑de... 20h View post View webpage ICON Plc How is AI transforming vaccine‑trial execution? On 31 March at 11:40 am at the World Vaccine Congress, join our interactive working group session, “Vaccine trials: How AI shifts execution from static plans to living sys... 22h View post View webpage ICON Plc Join ICON’s Dr. Anne Behringer on 25 March at 03:00 for a virtual presentation on “Cross-Border Recruitment in Clinical Trials: A Perspective on Operational Reality”. Learn more https://ow.ly/o25L50Yr8W3 11 Mar View post View webpage ICON Plc Attending #OCTSoutheast 10-11 March? Stop by booth \#37 to learn how we support biotechs with flexible clinical development, operational expertise and data‑driven decision‑making. https://lnkd.in/ehPmQF\_H 10 Mar View post View webpage ICON Plc Formulations in early clinical development require a delicate balance of flexibility, simplicity, and scientific rigor. In first‑in‑human trials, dose ranges can vary by 10–100 fold increase between the starting dose a... 10 Mar View post View webpage ICON Plc ICON has participated in 193 neurodegenerative and neuromuscular studies, enrolling 18,200+ patients at 4,800+ sites globally. Meet our experts at #ADPD2026, booth \#29 to learn how we can support your neurodegeneration ... 10 Mar View post View webpage ICON Plc Only one day until #OCT Southeast begins. ICON will be on site 10–11 March, ready to connect with biotechs looking to strengthen clinical delivery. Visit Booth \#37 to meet our team and discuss how our expertise supports... 9 Mar View post View webpage ICON Plc Meet the ICON team at Medidata NEXT New York. Our specialists will be available throughout the event to discuss how ICON is supporting sponsors to improve study build quality, streamline delivery and adopt technology wit... 9 Mar View post View webpage ICON Plc Join Steve Hunt at Medidata NEXT New York for a roundtable discussion on real world lessons from early adopters of Medidata Designer. Steve will share what effective adoption looks like in practice, where ICON teams are ... 6 Mar View post View webpage ICON Plc The oncology R&D landscape is rapidly evolving, driven by multi‑modality therapeutics, precision‑designed studies, and the growing measurable impact of AI on discovery and development. These shifts are reshaping how spon... 6 Mar View post View webpage ICON Plc Last week, our teams across ICON came together to recognise Rare Disease Day and raise awareness for the millions of people and families living with rare conditions. Colleagues took part in activities including creating... 6 Mar View post ICON Plc Join ICON at #OCT Southeast on 10 March at 9:30am EST as Shelley McLendon, Senior Vice President, Program Management, shares a CRO perspective on the global biotech sector. She will discuss the landscape shaping biotec... 5 Mar View post View webpage
